Analysts Predict a $62 Target for Docusign Inc (DOCU) Stock—What Could Drive It There?
UBS has recently raised Docusign Inc (DOCU) stock to Neutral rating, as announced on April 12, 2024, according to Finviz. Earlier, on January 16, 2024, Morgan Stanley had raised the stock rating, setting a price target of $64. for DOCU stock. Wells Fargo also reduced Underweight rating. Additionally, Daiwa Securities reduced Outperform rating on December […]
What’s Behind the -4.33% Drop in Pegasystems Inc. (PEGA) Stock? Find Out Now!
Loop Capital has recently raised Pegasystems Inc. (PEGA) stock to Buy rating, as announced on August 1, 2024, according to Finviz. Earlier, on July 31, 2024, JMP Securities had raised the stock from a Mkt Perform to Mkt Outperform, setting a price target of $85. William Blair also raised Outperform rating. Additionally, Barclays raised Equal […]
TD Cowen Just Initiated Lemonade Inc (LMND) Stock—What Does This Mean for Investors?
TD Cowen has recently initiated Lemonade Inc (LMND) stock to Market Perform rating, as announced on January 10, 2024, according to Finviz. Earlier, on December 1, 2023, Oppenheimer had reduced the stock from a Outperform to Perform. Morgan Stanley also initiated Underweight rating with a price target of $14. Additionally, BMO Capital Markets initiated Underperform […]
How Does Select Medical Holdings Corp (SEM) Stack Up Against Its Industry Peers?
BofA Securities has recently resumed Select Medical Holdings Corp (SEM) stock to Buy rating, as announced on August 20, 2024, according to Finviz. Earlier, on May 13, 2021, The Benchmark Company had reiterated the stock to Buy, setting a price target of $44. for SEM stock. BofA Securities also raised Buy rating with a price […]
Interpublic Group of Companies Inc (IPG) Stock: More Strategic Than Meets the Eye
Morgan Stanley has recently reduced Interpublic Group of Companies Inc (IPG) stock rating, as announced on July 22, 2024, according to Finviz. Earlier, on January 11, 2024, UBS had initiated the stock to Neutral, setting a price target of $36. Wells Fargo also reduced Equal Weight rating with a price target of $33. Additionally, BofA […]
Bunge Global SA (BG) Stock: Analyzing Its Quiet Power
Citigroup has recently reduced Bunge Global SA (BG) stock to Neutral rating, as announced on August 1, 2024, according to Finviz. Earlier, on February 9, 2024, HSBC Securities had raised the stock from a Hold to Buy, setting a price target of $105. for BG stock. Citigroup also initiated Buy rating with a price target […]
Conduent Inc (CNDT) Stock: Understanding Its Underlying Value
Noble Capital Markets has recently initiated Conduent Inc (CNDT) stock to Outperform rating, as announced on March 14, 2024, according to Finviz. Earlier, on November 9, 2021, Needham had reduced the stock from a Buy to Hold. JP Morgan also reduced Neutral rating. Additionally, Needham reiterated Buy rating on February 21, 2020, with a target […]
Lincoln National Corp (LNC) Stock: More Robust Than the Numbers Suggest?
Jefferies has recently raised Lincoln National Corp (LNC) stock to Buy rating, as announced on May 22, 2024, according to Finviz. Earlier, on February 12, 2024, Jefferies had raised the stock from a Underperform to Hold, setting a price target of $2622. JP Morgan also reduced Underweight rating with a price target of $26. Additionally, […]
Expensify Inc (EXFY) Stock: Beyond the Surface of Its Performance?
JMP Securities has recently raised Expensify Inc (EXFY) stock to Mkt Outperform rating, as announced on August 9, 2024, according to Finviz. Earlier, on May 28, 2024, Morgan Stanley had raised the stock rating. JP Morgan also initiated Underweight rating. Additionally, Loop Capital reduced Hold rating on August 9, 2023, with a target price of […]
Healthpeak Properties Inc (DOC) Stock: Greater Than Its Current Valuation?
Wedbush has recently raised Healthpeak Properties Inc (DOC) stock to Outperform rating, as announced on May 3, 2024, according to Finviz. Earlier, on April 26, 2024, Exane BNP Paribas had raised the stock from a Neutral to Outperform, setting a price target of $21. for DOC stock. Mizuho also resumed Buy rating with a price […]
